39. Eyezirgan - How topical Ganciclovir is changing our treatment of HSV (Dr. Parwez Hossain) episode artwork

EPISODE · Apr 15, 2025 · 32 MIN

39. Eyezirgan - How topical Ganciclovir is changing our treatment of HSV (Dr. Parwez Hossain)

from Blind Spot - The Eye Doctor's Podcast · host Zale Mednick

With the arrival of Eyezirgan (commercial available topical ganciclovir), we now have a more readily accessible preservative-free option for treatment of HSV.  So why is Eyezirgan a potentially important new player on the market?  How does one decide between oral or topical treatments for HSV, and is there a longer-term role for antivirals in the treatment of Zoster, in addition to just HSV? Dr. Parwez Hossain joins the podcast. This episode is sponsored by Thea Pharma Canada - https://www.theapharma.caBecome a supporter of this podcast: https://www.spreaker.com/podcast/blind-spot-the-eye-doctor-s-podcast--5819306/support.

Episode metadata supplied by the publisher feed · Published Apr 15, 2025

Embed this episode

Ready to play

39. Eyezirgan - How topical Ganciclovir is changing our treatment of HSV (Dr. Parwez Hossain)

0:00 32:06

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Blind Spot - The Eye Doctor's Podcast?

This episode is 32 minutes long.

When was this Blind Spot - The Eye Doctor's Podcast episode published?

This episode was published on April 15, 2025.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this Blind Spot - The Eye Doctor's Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!